We are committed to finding innovative prognosis-based intervention strategies to improve survival and cure chronic or fatal disease conditions such as COPD-emphysema, Cystic Fibrosis, IPF and Age-related disorders. We welcome potential investors, donors and partners to accelerate our theranostic development programs to help us fight the pathogenic cause of fatal conditions and bring novel prognosis-based intervention strategies faster to the bedside.